Tyra Biosciences (TYRA) Stock Forecast, Price Target & Predictions
TYRA Stock Forecast
Tyra Biosciences stock forecast is as follows: an average price target of $31.75 (represents a 100.06% upside from TYRA’s last price of $15.87) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
TYRA Price Target
TYRA Analyst Ratings
Buy
Tyra Biosciences Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Nov 11, 2024 | Mitchell Kapoor | H.C. Wainwright | $30.00 | $16.70 | 79.64% | 89.04% |
Oct 18, 2024 | Jason Zemansky | Bank of America Securities | $31.00 | $25.98 | 19.32% | 95.34% |
Sep 19, 2024 | Matt Biegler | Oppenheimer | $33.00 | $24.64 | 33.90% | 107.94% |
Aug 15, 2024 | Christopher Raymond | Raymond James | $33.00 | $21.57 | 52.99% | 107.94% |
Aug 08, 2024 | Mitchell Kapoor | H.C. Wainwright | $25.00 | $19.50 | 28.21% | 57.53% |
Mar 20, 2024 | Mitchell Kapoor | H.C. Wainwright | $23.00 | $17.37 | 32.41% | 44.93% |
Feb 03, 2023 | - | Oppenheimer | $17.00 | $13.30 | 27.82% | 7.12% |
10
Tyra Biosciences Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 3 | 6 |
Avg Price Target | $30.00 | $31.33 | $29.17 |
Last Closing Price | $15.87 | $15.87 | $15.87 |
Upside/Downside | 89.04% | 97.42% | 83.81% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 18, 2024 | Bank of America Securities | - | Buy | Upgrade |
Oct 11, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 07, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Sep 19, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Aug 15, 2024 | Piper Sandler | - | Overweight | Initialise |
Aug 08, 2024 | H.C. Wainwright | Buy | Buy | Hold |
Jul 08, 2024 | Cowen & Co. | Buy | Buy | Hold |
Jul 03, 2024 | Oppenheimer | Outperform | Outperform | Hold |
May 10, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Feb 03, 2023 | Oppenheimer | - | Outperform | Initialise |
10
Tyra Biosciences Financial Forecast
Tyra Biosciences Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - |
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Tyra Biosciences EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Tyra Biosciences Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $-31.97M | $-29.37M | $-28.15M | $-29.25M | $-32.82M | $-31.06M | $-30.91M | $-28.70M | $-28.76M | $-23.48M | $-23.96M |
High Forecast | $-31.97M | $-29.37M | $-28.15M | $-29.25M | $-32.82M | $-31.06M | $-30.91M | $-25.71M | $-24.07M | $-23.48M | $-23.96M |
Low Forecast | $-31.97M | $-29.37M | $-28.15M | $-29.25M | $-32.82M | $-31.06M | $-30.91M | $-31.69M | $-32.87M | $-23.48M | $-23.96M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Tyra Biosciences SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
SG&A | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | - | - | - | - | - | - | - | - | - | - | - |
High Forecast | - | - | - | - | - | - | - | - | - | - | - |
Low Forecast | - | - | - | - | - | - | - | - | - | - | - |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Tyra Biosciences EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | - | - | - | - | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - | - | - | - | - |
Avg Forecast | $-0.54 | $-0.50 | $-0.48 | $-0.50 | $-0.56 | $-0.53 | $-0.53 | $-0.49 | $-0.49 | $-0.40 | $-0.41 |
High Forecast | $-0.54 | $-0.50 | $-0.48 | $-0.50 | $-0.56 | $-0.53 | $-0.53 | $-0.44 | $-0.41 | $-0.40 | $-0.41 |
Low Forecast | $-0.54 | $-0.50 | $-0.48 | $-0.50 | $-0.56 | $-0.53 | $-0.53 | $-0.54 | $-0.56 | $-0.40 | $-0.41 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - |
Forecast
Tyra Biosciences Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
RAPT | RAPT Therapeutics | $1.07 | $30.71 | 2770.09% | Hold |
IPSC | Century Therapeutics | $1.26 | $15.00 | 1090.48% | Buy |
PMVP | PMV Pharmaceuticals | $1.57 | $18.00 | 1046.50% | Buy |
XLO | Xilio Therapeutics | $0.94 | $7.00 | 644.68% | Buy |
HOWL | Werewolf Therapeutics | $1.64 | $12.00 | 631.71% | Buy |
MOLN | Molecular Partners | $5.20 | $29.00 | 457.69% | Buy |
CCCC | C4 Therapeutics | $4.05 | $13.50 | 233.33% | Buy |
STOK | Stoke Therapeutics | $11.31 | $30.60 | 170.56% | Buy |
CGEM | Cullinan Oncology | $12.58 | $31.50 | 150.40% | Buy |
ERAS | Erasca | $2.64 | $6.50 | 146.21% | Buy |
MLYS | Mineralys Therapeutics | $12.60 | $30.00 | 138.10% | Buy |
TYRA | Tyra Biosciences | $15.87 | $31.75 | 100.06% | Buy |
PHVS | Pharvaris | $20.50 | $39.67 | 93.51% | Buy |
DSGN | Design Therapeutics | $5.48 | $9.67 | 76.46% | Buy |
CNTB | Connect Biopharma | $1.05 | $1.50 | 42.86% | Buy |
EWTX | Edgewise Therapeutics | $31.95 | $45.00 | 40.85% | Buy |
IKNA | Ikena Oncology | $1.70 | $1.33 | -21.76% | Buy |
GRCL | Gracell Bio | $10.25 | $6.00 | -41.46% | Buy |